000 | 01932 a2200565 4500 | ||
---|---|---|---|
005 | 20250517133143.0 | ||
264 | 0 | _c20171025 | |
008 | 201710s 0 0 eng d | ||
022 | _a2051-5960 | ||
024 | 7 |
_a10.1186/s40478-016-0403-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYsselstein, Daniel | |
245 | 0 | 0 |
_aEndosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity. _h[electronic resource] |
260 |
_bActa neuropathologica communications _c01 2017 |
||
300 |
_a3 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study | ||
650 | 0 | 4 | _aAdenoviridae |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aCell Membrane _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
650 | 0 | 4 | _aEscherichia coli |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
650 | 0 | 4 |
_aLewy Body Disease _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeuroprotective Agents _xmetabolism |
650 | 0 | 4 |
_aPeptides _xmetabolism |
650 | 0 | 4 |
_aProtein Aggregation, Pathological _xdrug therapy |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aRecombinant Proteins _xdrug effects |
650 | 0 | 4 |
_aUnilamellar Liposomes _xchemistry |
650 | 0 | 4 |
_aalpha-Synuclein _xdrug effects |
700 | 1 | _aDehay, Benjamin | |
700 | 1 | _aCostantino, Isabel M | |
700 | 1 | _aMcCabe, George P | |
700 | 1 | _aFrosch, Matthew P | |
700 | 1 | _aGeorge, Julia M | |
700 | 1 | _aBezard, Erwan | |
700 | 1 | _aRochet, Jean-Christophe | |
773 | 0 |
_tActa neuropathologica communications _gvol. 5 _gno. 1 _gp. 3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s40478-016-0403-7 _zAvailable from publisher's website |
999 |
_c26767117 _d26767117 |